Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T49898 | Target Info | |||
Target Name | Cyclin-dependent kinase 1 (CDK1) | ||||
Synonyms | P34CDC2; P34 protein kinase; CDKN1; CDC28A; CDC2 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CDK1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Adapter proteins | [+] 1 Adapter proteins | + | |||
Interacting Target Name | Sequestosome-1 p62 (SQSTM1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-binding protein p62; Sequestosome-1; Phosphotyrosine-independent ligand for the Lck SH2 domain of 62kDa; Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa; OSIL; ORCA; EBIAP; EBI3-associated protein of 60 kDa | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Biochemical Activity | [1] | |||
4 | Reconstituted Complex | [1] | |||
Cell cycle related proteins | [+] 3 Cell cycle related proteins | + | |||
Interacting Target Name | Cyclin A2 (CCNA2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclin-A2; Cyclin-A; Cyclin A; CCNA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-Western | [5] | |||
Interacting Target Name | G1/S-specific cyclin-D1 (CCND1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRAD1 oncogene; PRAD1; Cyclin D1; BCL-1 oncogene; BCL-1; BCL1; B-cell lymphoma 1 protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-Western | [7] | |||
Interacting Target Name | G1/S-specific cyclin-E1 (CCNE1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G1/S-specific cyclin E; Cyclin E; CCNE | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Co-purification | [8] | |||
Ester hydrolases | [+] 2 Ester hydrolases | + | |||
Interacting Protein Name | Cyclin-dependent kinase inhibitor 3 (CDKN3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDI1; CIP2; KAP; KAP1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [10] | |||
3 | Yeast two hybrid | [10] | |||
Interacting Target Name | M-phase inducer phosphatase 3 (MPIP3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Dual specificity phosphatase Cdc25C; Cdc25C phosphatase | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [11] | |||
2 | Reconstituted Complex | [12] | |||
Histones | [+] 1 Histones | + | |||
Interacting Protein Name | Histone H1.1 (HIST1H1A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | H1.1; H1A; H1F1; HIST1 | ||||
Evidence Score (E-score) | 13 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Biochemical Activity | [14] | |||
3 | Biochemical Activity | [15] | |||
4 | Biochemical Activity | [16] | |||
5 | Biochemical Activity | [17] | |||
6 | Biochemical Activity | [18] | |||
7 | Biochemical Activity | [1] | |||
8 | Biochemical Activity | [19] | |||
9 | Biochemical Activity | [20] | |||
10 | Biochemical Activity | [21] | |||
11 | Biochemical Activity | [22] | |||
12 | Biochemical Activity | [23] | |||
13 | Biochemical Activity | [24] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [25] | |||
2 | Protein-Fragment Complementation Assay | [26] | |||
3 | Yeast two hybrid | [27] | |||
Interacting Target Name | Tyrosine-protein kinase Lyn (JTK8) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | V-yes-1 Yamaguchi sarcoma viral related oncogene homolog; p56Lyn; p53Lyn; Lck/Yes-related novel protein tyrosine kinase | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Biochemical Activity | [28] | |||
Membrane-bounded channels | [+] 2 Membrane-bounded channels | + | |||
Interacting Target Name | G2/mitotic-specific cyclin B1 (CCNB1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G2/mitotic-specific cyclin-B1; Cyclin B1; CCNB | ||||
Evidence Score (E-score) | 17 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [9] | |||
4 | Affinity Capture-MS | [29] | |||
5 | Affinity Capture-MS | [3] | |||
6 | Affinity Capture-Western | [30] | |||
7 | Affinity Capture-Western | [31] | |||
8 | Affinity Capture-Western | [32] | |||
9 | Affinity Capture-Western | [33] | |||
10 | Affinity Capture-Western | [1] | |||
11 | Biochemical Activity | [34] | |||
12 | Biochemical Activity | [19] | |||
13 | Co-fractionation | [35] | |||
14 | Co-fractionation | [19] | |||
15 | Co-purification | [36] | |||
16 | Co-purification | [17] | |||
17 | Reconstituted Complex | [37] | |||
Interacting Protein Name | G2/mitotic-specific cyclin-B2 (CCNB2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HsT17299 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [9] | |||
4 | Affinity Capture-MS | [29] | |||
5 | Affinity Capture-MS | [3] | |||
6 | Co-fractionation | [35] | |||
One-carbon transferases | [+] 1 One-carbon transferases | + | |||
Interacting Target Name | Enhancer of zeste homolog 2 (EZH2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Lysine N-methyltransferase 6; Lysine Nmethyltransferase 6; KMT6; Histone-lysine N-methyltransferase EZH2; Histonelysine Nmethyltransferase EZH2; EZH2 Y641N mutations; EZH2 Y641F mutations; ENX-1; ENX1 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [38] | |||
2 | Affinity Capture-Western | [39] | |||
3 | Biochemical Activity | [40] | |||
4 | Biochemical Activity | [39] | |||
5 | Biochemical Activity | [38] | |||
6 | Biochemical Activity | [41] | |||
7 | Biochemical Activity | [42] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [43] | |||
2 | Biochemical Activity | [44] | |||
Transcription regulators | [+] 2 Transcription regulators | + | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [45] | |||
2 | Biochemical Activity | [45] | |||
3 | Biochemical Activity | [46] | |||
Interacting Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; MOP1; Member of PAS protein 1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1; Hypoxia inducible factor 1; HIF-1-alpha; HIF-1alpha; HIF1-alpha; HIF-1 alpha; HIF1 alpha; Class E basic helix-loop-helix protein 78; bHLHe78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [47] | |||
2 | Affinity Capture-Western | [48] | |||
Other proteins | [+] 5 Other proteins | + | |||
Interacting Protein Name | Cyclin-dependent kinases regulatory subunit 1 (CKS1B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CKS1; PNAS.16; PNAS.18; ckshs1 | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [29] | |||
4 | Affinity Capture-MS | [3] | |||
5 | Affinity Capture-Western | [49] | |||
6 | Affinity Capture-Western | [50] | |||
7 | Co-fractionation | [35] | |||
8 | Co-fractionation | [51] | |||
9 | Yeast two hybrid | [52] | |||
Interacting Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA-6; MDA6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-MS | [9] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Affinity Capture-Western | [53] | |||
5 | Affinity Capture-Western | [5] | |||
Interacting Protein Name | Cyclin-dependent kinases regulatory subunit 2 (CKS2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CKSHS2 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-MS | [4] | |||
3 | Affinity Capture-MS | [29] | |||
4 | Affinity Capture-MS | [3] | |||
5 | Affinity Capture-Western | [49] | |||
Interacting Protein Name | DNA damage-inducible transcript 1 protein (GADD45A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DDIT1; GADD45 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [54] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Affinity Capture-Western | [30] | |||
4 | Reconstituted Complex | [54] | |||
5 | Reconstituted Complex | [14] | |||
Interacting Target Name | CDK inhibitor 1B p27Kip1 (CDKN1B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p27Kip1; KIP1; Cyclin-dependent kinase inhibitor p27; Cyclindependent kinase inhibitor p27; Cyclin-dependent kinase inhibitor 1B | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [6] | |||
2 | Affinity Capture-MS | [9] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Affinity Capture-Western | [55] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Phosphorylation of p62 by cdk1 controls the timely transit of cells through mitosis and tumor cell proliferation. Mol Cell Biol. 2011 Jan;31(1):105-17. | ||||
REF 2 | Both p62/SQSTM1-HDAC6-dependent autophagy and the aggresome pathway mediate CDK1 degradation in human breast cancer. Sci Rep. 2017 Aug 30;7(1):10078. | ||||
REF 3 | The protein interaction landscape of the human CMGC kinase group. Cell Rep. 2013 Apr 25;3(4):1306-20. | ||||
REF 4 | Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy. Sci Signal. 2015 Apr 7;8(371):rs3. | ||||
REF 5 | Destabilization of CARP mRNAs by aloe-emodin contributes to caspase-8-mediated p53-independent apoptosis of human carcinoma cells. J Cell Biochem. 2011 Apr;112(4):1176-91. | ||||
REF 6 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 7 | Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell. 1993 Sep;4(9):897-906. | ||||
REF 8 | Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science. 1992 Sep 18;257(5077):1689-94. | ||||
REF 9 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 10 | KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1731-5. | ||||
REF 11 | Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators. Cell Rep. 2016 Nov 22;17(9):2488-2501. | ||||
REF 12 | An essential phosphorylation-site domain of human cdc25C interacts with both 14-3-3 and cyclins. J Biol Chem. 2000 Sep 15;275(37):28849-57. | ||||
REF 13 | RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. J Biol Chem. 2002 Jan 4;277(1):502-8. | ||||
REF 14 | Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 1999 May 6;18(18):2892-900. | ||||
REF 15 | The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity. Oncogene. 1997 Jan 30;14(4):491-8. | ||||
REF 16 | PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell. 1998 Dec;2(6):877-85. | ||||
REF 17 | Reconstitution of cyclin-dependent cdc2 and cdk2 kinase activities in vitro. J Biol Chem. 1993 Sep 25;268(27):20433-42. | ||||
REF 18 | BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet. 2002 Mar;30(3):285-9. | ||||
REF 19 | Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities. J Biol Chem. 1993 Sep 25;268(27):20443-51. | ||||
REF 20 | Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J Cell Biol. 1995 Jun;129(6):1617-28. | ||||
REF 21 | Hip2 ubiquitin-conjugating enzyme overcomes radiation-induced G2/M arrest. Biochim Biophys Acta. 2013 Dec;1833(12):2911-2921. | ||||
REF 22 | Phosphorylation regulates SIRT1 function. PLoS One. 2008;3(12):e4020. | ||||
REF 23 | The anaphase-promoting complex or cyclosome supports cell survival in response to endoplasmic reticulum stress. PLoS One. 2012;7(4):e35520. | ||||
REF 24 | Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression. Oncogene. 2008 Nov 6;27(52):6635-45. | ||||
REF 25 | Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. J Proteome Res. 2008 Mar;7(3):1067-77. | ||||
REF 26 | The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92. | ||||
REF 27 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 28 | Activation of Src-like p56/p53lyn tyrosine kinase by ionizing radiation. J Biol Chem. 1994 Aug 12;269(32):20739-43. | ||||
REF 29 | A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015 Oct 22;163(3):712-23. | ||||
REF 30 | Identification of a functional domain in a GADD45-mediated G2/M checkpoint. J Biol Chem. 2000 Nov 24;275(47):36892-8. | ||||
REF 31 | Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction. EMBO J. 2000 Mar 15;19(6):1378-88. | ||||
REF 32 | Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition. Cancer Sci. 2010 Jun;101(6):1403-8. | ||||
REF 33 | cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. EMBO J. 2008 Apr 9;27(7):1005-16. | ||||
REF 34 | A novel RING finger protein, human enhancer of invasion 10, alters mitotic progression through regulation of cyclin B levels. Mol Cell Biol. 2003 Mar;23(6):2109-22. | ||||
REF 35 | Panorama of ancient metazoan macromolecular complexes. Nature. 2015 Sep 17;525(7569):339-44. | ||||
REF 36 | Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Exp Mol Pathol. 2009 Apr;86(2):87-94. | ||||
REF 37 | Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Mol Cell Biol. 1995 Jan;15(1):345-50. | ||||
REF 38 | CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol. 2011 Jan;13(1):87-94. | ||||
REF 39 | Fine-tuning the stimulation of MLL1 methyltransferase activity by a histone H3-based peptide mimetic. FASEB J. 2011 Mar;25(3):960-7. | ||||
REF 40 | Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol. 2010 Nov;12(11):1108-14. | ||||
REF 41 | Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 2010 Dec 1;24(23):2615-20. | ||||
REF 42 | PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression. Nucleic Acids Res. 2015 Apr 20;43(7):3591-604. | ||||
REF 43 | Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34(cdc2). Biochem Biophys Res Commun. 2001 May 4;283(2):507-12. | ||||
REF 44 | The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A. J Mol Biol. 2000 Jul 14;300(3):503-18. | ||||
REF 45 | Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells. Oncogene. 2012 Nov 22;31(47):4946-59. | ||||
REF 46 | Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis. Nucleic Acids Res. 2014 Dec 16;42(22):13573-87. | ||||
REF 47 | The TIP60 Complex Is a Conserved Coactivator of HIF1A. Cell Rep. 2016 Jun 28;16(1):37-47. | ||||
REF 48 | Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1 to promote cell-cycle progression. Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):E3325-34. | ||||
REF 49 | Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A. Mol Cell. 2008 May 9;30(3):290-302. | ||||
REF 50 | Ectopic expression of cdc2/cdc28 kinase subunit Homo sapiens 1 uncouples cyclin B metabolism from the mitotic spindle cell cycle checkpoint. Mol Cell Biol. 1998 Nov;18(11):6224-37. | ||||
REF 51 | A census of human soluble protein complexes. Cell. 2012 Aug 31;150(5):1068-81. | ||||
REF 52 | A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226. | ||||
REF 53 | APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell. 2007 Aug 3;27(3):462-73. | ||||
REF 54 | The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem. 2000 Jun 2;275(22):16602-8. | ||||
REF 55 | S10 phosphorylation of p27 mediates atRA induced growth arrest in ovarian carcinoma cell lines. J Cell Physiol. 2008 Nov;217(2):558-68. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.